Two jabs mostly prevent hospitalization with Delta variant--UK body | Inquirer News

Two jabs mostly prevent hospitalization with Delta variant–UK body

/ 03:04 PM June 15, 2021

A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

 A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS FILE PHOTO

LONDON — Two doses of Covid-19 vaccines are “highly effective” in preventing hospital admission with the Delta variant, Public Health England said on Monday.

Scientists said two jabs of the Pfizer/BioNTech vaccine stopped the need for in-patient treatment in 96 percent of cases.

Article continues after this advertisement

With a double dose of the Oxford/AstraZeneca shot, the rate was 92 percent, PHE added.

FEATURED STORIES

The findings were published as Britain grapples with a surge in coronavirus cases, most of which were of the Delta strain, which first emerged in India.

The increase is again raising concerns about the potential strain on hospitals, prompting calls to postpone a planned lifting of all social distancing curbs on June 21.

Article continues after this advertisement

The restrictions have been in place since January, when the Alpha strain of the coronavirus, which was first identified in Kent, southeast England, spread rapidly.

Article continues after this advertisement

The government, which began a mass-vaccination program with the Pfizer/BioNTech jab in December last year, is pushing for more people to get two jabs.

Article continues after this advertisement

PHE said the vaccine effectiveness for the Delta variant is comparable to that for the Alpha strain.

Head of immunization Mary Ramsay said: “These hugely important findings confirm that the vaccines offer significant protection against hospitalization from the Delta variant.”

Article continues after this advertisement

Further investigations were under way to determine the level of protection against death from the Delta variant, PHE said, but added that it was expected to be “high”.

The public health body looked at 14,019 cases of the new variant in England between April 12 and June 4.

Previous analysis indicated that one dose of vaccine is 17 percent less effective in preventing a person developing symptoms from the Delta variant than the Alpha one.

But the latest research showed there was only a small difference after two doses.

Simon Kolstoe, senior lecturer in evidence-based healthcare at the University of Portsmouth, said the inoculation program was clearly working.

Nearly 57 percent of the UK’s adult population has had two doses, according to government statistics.

But he added: “We can only be confident in lifting all restrictions once we know that the link between large-scale infections and hospital admissions has been broken.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

“The vaccine certainly seems to be doing its job in breaking this link but a few more weeks to get more people vaccinated certainly seems like a sensible option.”

TAGS: Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.